Millennium Management’s XBiotech XBIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $248K | Sell |
105,540
-29,898
| -22% | -$72.3K | ﹤0.01% | 5083 |
|
|
2025
Q4 | $324K | Sell |
135,438
-280,906
| -67% | -$693K | ﹤0.01% | 5219 |
|
|
2025
Q3 | $1.11M | Sell |
416,344
-135,003
| -24% | -$400K | ﹤0.01% | 4542 |
|
|
2025
Q2 | $1.64M | Buy |
551,347
+468,991
| +569% | +$1.36M | ﹤0.01% | 4048 |
|
|
2025
Q1 | $267K | Sell |
82,356
-181,166
| -69% | -$625K | ﹤0.01% | 5156 |
|
|
2024
Q4 | $1.04M | Sell |
263,522
-17,497
| -6% | -$119K | ﹤0.01% | 4163 |
|
|
2024
Q3 | $2.17M | Sell |
281,019
-80,642
| -22% | -$530K | ﹤0.01% | 3633 |
|
|
2024
Q2 | $1.86M | Sell |
361,661
-565,707
| -61% | -$4.36M | ﹤0.01% | 3593 |
|
|
2024
Q1 | $7.54M | Buy |
927,368
+131,642
| +17% | +$754K | ﹤0.01% | 2456 |
|
|
2023
Q4 | $3.18M | Sell |
795,726
-135,718
| -15% | -$540K | ﹤0.01% | 3186 |
|
|
2023
Q3 | $3.84M | Sell |
931,444
-28,314
| -3% | -$142K | ﹤0.01% | 2963 |
|
|
2023
Q2 | $5.7M | Buy |
959,758
+914,107
| +2,002% | +$4.12M | ﹤0.01% | 2560 |
|
|
2023
Q1 | $157K | Sell |
45,651
-6,593
| -13% | -$24.6K | ﹤0.01% | 5269 |
|
|
2022
Q4 | $183K | Sell |
52,244
-85,743
| -62% | -$292K | ﹤0.01% | 5365 |
|
|
2022
Q3 | $500K | Sell |
137,987
-146,692
| -52% | -$691K | ﹤0.01% | 4973 |
|
|
2022
Q2 | $1.6M | Buy |
284,679
+267,953
| +1,602% | +$1.8M | ﹤0.01% | 3924 |
|
|
2022
Q1 | $145K | Sell |
16,726
-2,071
| -11% | -$20.8K | ﹤0.01% | 5984 |
|
|
2021
Q4 | $209K | Buy |
18,797
+3,787
| +25% | +$49.3K | ﹤0.01% | 5874 |
|
|
2021
Q3 | $194K | Buy |
+15,010
| New | +$239K | ﹤0.01% | 6132 |
|
|
2021
Q2 | – | Sell |
-10,056
| Closed | -$173K | – | 7185 |
|
|
2021
Q1 | $173K | Buy |
+10,056
| New | +$188K | ﹤0.01% | 5534 |
|
|
2020
Q2 | – | Sell |
-30,047
| Closed | -$319K | – | 4655 |
|
|
2020
Q1 | $319K | Sell |
30,047
-108,510
| -78% | -$1.77M | ﹤0.01% | 3144 |
|
|
2019
Q4 | $2.59M | Buy |
138,557
+121,895
| +732% | +$1.57M | ﹤0.01% | 2447 |
|
|
2019
Q3 | $174K | Buy |
16,662
+5,146
| +45% | +$41.9K | ﹤0.01% | 3828 |
|
|
2019
Q2 | $87K | Sell |
11,516
-200,832
| -95% | -$1.75M | ﹤0.01% | 3909 |
|
|
2019
Q1 | $2.34M | Buy |
212,348
+163,312
| +333% | +$1.32M | ﹤0.01% | 2312 |
|
|
2018
Q4 | $249K | Sell |
49,036
-113,392
| -70% | -$465K | ﹤0.01% | 3306 |
|
|
2018
Q3 | $517K | Sell |
162,428
-45,340
| -22% | -$177K | ﹤0.01% | 3242 |
|
|
2018
Q2 | $931K | Buy |
+207,768
| New | +$939K | ﹤0.01% | 2883 |
|
|
2018
Q1 | – | Sell |
-21,714
| Closed | -$86K | – | 4140 |
|
|
2017
Q4 | $86K | Buy |
+21,714
| New | +$91.4K | ﹤0.01% | 3681 |
|
|
2016
Q1 | – | Sell |
-15,771
| Closed | -$171K | – | 3714 |
|
|
2015
Q4 | $171K | Buy |
15,771
+3,323
| +27% | +$42.4K | ﹤0.01% | 3149 |
|
|
2015
Q3 | $186K | Sell |
12,448
-554
| -4% | -$9.7K | ﹤0.01% | 3138 |
|
|
2015
Q2 | $235K | Buy |
+13,002
| New | +$270K | ﹤0.01% | 2987 |
|
Other funds holding XBIT
VCM
RC
BCM
VFT
Millennium Management's XBIT Position: Q1 2026 in Review
Millennium Management reduced its XBiotech (XBIT) stake by 22% in Q1 2026, selling an estimated $72.3K and leaving 105,540 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #5083.
Millennium Management first reported a position in XBIT in Q2 2015 and has held it in 32 quarters since. The position peaked at $7.54M in Q1 2024. 37 funds tracked by Wall St. Rank hold XBIT as of Q1 2026.
- Millennium Management held 105,540 shares of XBiotech worth $248K as of Q1 2026.
- Millennium Management sold 29,898 XBiotech shares in Q1 2026, an estimated $72.3K.
- XBiotech made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5083 holding.
- Millennium Management first reported a position in XBiotech in Q2 2015 and has held it in 32 quarters since.
- Millennium Management's XBiotech position peaked at $7.54M in Q1 2024.
- 37 funds tracked by Wall St. Rank held XBiotech as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.